ClassID:

92140

C07C69/12 - CPC Classification

Classification description:

Esters of carboxylic acids; Esters of carbonic or haloformic acids; Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen Acetic acid esters

Sub-classes:
Recent Application in this class:
#1
20230024745
2023-01-26

ESTERIFICATION OF ACETIC ACID RECOVERED FROM WOOD ACETYLATION WITH ETHER-ALCOHOLS

#2
20190382431
2019-12-19

Hemicellulose processing method

#3
20190300465
2019-10-03

Method for producing alcohol compound

#4
20180369794
2018-12-27

Carbonylation process using a pretreated zeolite catalyst

#5
20180118657
2018-05-03

METHODS FOR INHIBITING MUSCLE ATROPHY

#6
20180085344
2018-03-29

Method of use of diterpenoid derivatives as anticancer agents

#7
20180022683
2018-01-25

Method for preparing substituted alkyl cycloalkanones

#8
20170174611
2017-06-22

Compound isolated from var. and preparation method and applications thereof

#9
20170092866
2017-03-30

Fullerene derivatives

#10
20170029741
2017-02-02

Organoleptic compounds

#11
20170029740
2017-02-02

NOVEL ORGANOLEPTIC COMPOUNDS

#12
20160368853
2016-12-22

Monoesters, inner complex salts or monoester salts of hexahydro-beta-acid and application thereof as animal feed additives

#13
20160272564
2016-09-22

1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient

#14
20160168064
2016-06-16

Purification method

#15
20150372349
2015-12-24

NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE

#16
20140243519
2014-08-28

Methods and intermediates for preparing macrolactams

#17
20140206605
2014-07-24

Crystal forms of a HCV protease inhibitor

#18
20140200343
2014-07-17

Process and intermediates for preparing macrolactams

#19
20140162996
2014-06-12

Modulators of development of adipocyte and cancer cells

#20
20140121187
2014-05-01

1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient

#21
20130225594
2013-08-29

Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions

#22
20130203712
2013-08-08

Methods for inhibiting muscle atrophy

#23
20110251421
2011-10-13

Ester prodrugs of prostratin and related phorbol compounds

#24
20090163587
2009-06-25

Ester prodrugs of prostratin and related phorbol compounds

#25
15277700
2017-10-24

Method of use of diterpenoid derivatives as anticancer agents

#26
14755049
2016-10-04

Negative tone developer composition for extreme ultraviolet lithography